Dr. Perl on Genetic Testing and Targeted Therapies in AML
November 10th 2022Alexander E. Perl, MD, MS, associate professor, medicine, the Hospital of the University of Pennsylvania, discusses why genetic testing is important for determining targeted therapies for patients with acute myeloid leukemia.
Read More